Search Results for: name
PCSK9 Gene Hypercholesterolemia Autosomal Dominant Type 3 Genetic Test Cost
The PCSK9 Gene Hypercholesterolemia Autosomal Dominant Type 3 Genetic Test is a specialized diagnostic tool used to identify mutations in the PCSK9 gene, which can lead to Autosomal Dominant Hypercholesterolemia Type 3 (ADH3). This condition is characterized by significantly elevated levels of cholesterol in the blood, increasing the risk of heart disease and stroke. The PCSK9 gene plays a crucial role in regulating cholesterol levels in the body, and mutations can result in decreased clearance of low-density lipoprotein cholesterol (LDL-C), often referred to as "bad" cholesterol, from the bloodstream. The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. By analyzing a patient's DNA sample, usually obtained through a blood draw or a cheek swab, the test can confirm the presence of specific genetic variations associated with ADH3. This information is crucial for the early diagnosis and management of the condition, allowing for personalized treatment strategies that may include lifestyle changes, medication, or other interventions aimed at reducing cholesterol levels and mitigating cardiovascular risk. The cost of the PCSK9 Gene Hypercholesterolemia Autosomal Dominant Type 3 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem high, the value of early detection and the potential to significantly impact the patient's health and quality of life can be immeasurable. Early and accurate diagnosis through genetic testing can empower patients and their healthcare providers to take proactive steps in managing hypercholesterolemia effectively.
LDLRAP1 Gene Hypercholesterolemia Autosomal Recessive Genetic Test Cost
The LDLRAP1 gene plays a crucial role in regulating cholesterol levels within the body. Mutations in this gene can lead to a condition known as autosomal recessive hypercholesterolemia, characterized by elevated levels of low-density lipoprotein (LDL) cholesterol in the blood. This condition increases the risk of developing early cardiovascular diseases. To diagnose this genetic predisposition, a specific genetic test targeting the LDLRAP1 gene is available. Conducted at DNA Labs UAE, this test is designed to detect mutations in the LDLRAP1 gene that are responsible for the autosomal recessive form of hypercholesterolemia. By analyzing a patient's DNA, the test can confirm the presence of these genetic variations, providing essential information for early diagnosis and management of the condition. The cost of the LDLRAP1 gene hypercholesterolemia autosomal recessive genetic test is 4400 AED. This investment can be crucial for individuals with a family history of hypercholesterolemia, enabling them and their healthcare providers to take proactive steps in managing their cholesterol levels and reducing the risk of heart disease.
B4GALT1 Gene Glycosylation Disorder Type 2D Genetic Test Cost
The B4GALT1 gene glycosylation disorder, also known as type 2D, is a rare genetic condition that affects the body's ability to properly glycosylate proteins and lipids, which are crucial processes for normal cellular function. This disorder can lead to a wide range of symptoms, including developmental delays, neurological issues, and other systemic complications. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the faulty gene, one from each parent, to be affected. To diagnose this condition, a specific genetic test is available at DNA Labs UAE, which focuses on identifying mutations in the B4GALT1 gene. This test is crucial for confirming the diagnosis, allowing for appropriate management and treatment plans to be established for affected individuals. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for the presence of mutations in the B4GALT1 gene. The cost of the B4GALT1 gene glycosylation disorder type 2D genetic test at DNA Labs UAE is 4400 AED. While the test price may seem high, it is a critical step in the diagnosis and management of this rare condition, providing essential information for healthcare providers, patients, and their families. Early diagnosis through genetic testing can significantly impact the quality of life for those affected by offering targeted treatments and interventions.
COG7 Gene Glycosylation Disorder Type 2E Genetic Test Cost
The COG7 Gene Glycosylation Disorder Type 2E Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the COG7 gene, which are implicated in Congenital Disorders of Glycosylation Type IIe (CDG-IIe). This condition is a rare genetic disorder that affects the normal process of glycosylation - the attachment of sugars to proteins and lipids, which is crucial for various cellular functions. Symptoms of the disorder can include developmental delay, neurological issues, and abnormalities in various organs. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect mutations in the COG7 gene, helping in the accurate diagnosis of CDG-IIe. This information is vital for understanding the prognosis of the disorder and can guide treatment and management strategies. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the test ensures accuracy and reliability, providing essential genetic insights for affected individuals and their families.
SLC35A1 Gene Glycosylation Disorder Type 2F Genetic Test Cost
The SLC35A1 gene glycosylation disorder type 2F genetic test is a specialized diagnostic procedure aimed at identifying mutations in the SLC35A1 gene, which are associated with Congenital Disorders of Glycosylation (CDG). Type 2F CDG, a rare genetic condition, affects the body's ability to properly glycosylate proteins and lipids, which are crucial for various cellular functions. Symptoms of the disorder can vary widely among individuals but often include developmental delay, neurological issues, and problems with the digestive system, among others. Performed at DNA Labs UAE, this test is essential for confirming a diagnosis of SLC35A1-CDG and facilitating appropriate management and treatment plans for affected individuals. The test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific genetic alterations in the SLC35A1 gene that are indicative of the disorder. The cost of the SLC35A1 gene glycosylation disorder type 2F genetic test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the expertise required to accurately interpret the results, and the potential impact this diagnosis can have on patient care. For families and individuals facing symptoms suggestive of a congenital disorder of glycosylation, this test provides a critical step towards understanding their condition and navigating the complexities of genetic disorders.
COG1 Gene Glycosylation Disorder Type 2G Genetic Test Cost
The "COG1 Gene Glycosylation Disorder Type 2G Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the COG1 gene, which are associated with Congenital Disorders of Glycosylation (CDG) Type 2G. These disorders are a group of rare genetic conditions that affect the normal process of adding sugar chains to proteins (glycosylation), which is crucial for proper protein function and cellular operations. Mutations in the COG1 gene can lead to various symptoms, including developmental delays, neurological issues, and abnormalities in organ function. The test is particularly valuable for individuals showing symptoms suggestive of CDG Type 2G, families with a history of the condition, or healthcare providers seeking a diagnosis for their patients presenting with related symptoms. Performed at the state-of-the-art facilities of DNA Labs UAE, the test involves analyzing the patient's DNA to look for specific genetic alterations in the COG1 gene that confirm the diagnosis of CDG Type 2G. The cost of the COG1 Gene Glycosylation Disorder Type 2G Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to identify the genetic mutation responsible for the disorder, offering crucial information that can guide treatment decisions, management plans, and provide insight into the prognosis of the condition. Additionally, the results can have significant implications for family planning and the genetic counseling of affected families, helping them understand the risks of the disorder being passed on to future generations.
COG8 Gene Glycosylation Disorder Type 2H Genetic Test Cost
The COG8 Gene Glycosylation Disorder Type 2H Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the COG8 gene, which are associated with a rare genetic disorder known as Congenital Disorders of Glycosylation Type IIh (CDG-IIh). This condition is part of a larger group of diseases that affect the process by which sugars are attached to proteins (glycosylation), which is crucial for proper cellular function and development. CDG-IIh is characterized by a wide range of symptoms, including developmental delay, neurological issues, and abnormalities in liver function, among others. Early and accurate diagnosis through genetic testing is vital for managing the condition, as it can guide treatment options and help in understanding the prognosis. The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high standards of accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the sophisticated nature of the technology and expertise involved in conducting the analysis and interpreting the results. Individuals who are suspected of having CDG-IIh based on clinical symptoms or family history may be recommended to undergo this test. It is also useful for families seeking to understand their genetic makeup in relation to this condition, especially for planning future pregnancies. By offering this test, DNA Labs UAE provides essential support to patients and families affected by CDG-IIh, contributing to better healthcare outcomes through precision medicine.
COG5 Gene Glycosylation Disorder Type 2I Genetic Test Cost
The COG5 Gene Glycosylation Disorder Type 2I Genetic Test is a specialized diagnostic tool designed to identify mutations in the COG5 gene, which are associated with Congenital Disorders of Glycosylation (CDG). Type 2I CDG is a rare genetic condition that affects the normal process of adding sugar chains to proteins (glycosylation), crucial for various bodily functions. Symptoms of this disorder can range from mild to severe and may include developmental delay, neurological issues, and abnormalities in organ function. This genetic test involves analyzing the patient's DNA to detect specific mutations in the COG5 gene that are known to cause the disorder. Early diagnosis through this test can be pivotal in managing symptoms and improving the quality of life for affected individuals. The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high accuracy and reliability of results. The cost of the COG5 Gene Glycosylation Disorder Type 2I Genetic Test is set at 4400 AED. Given the complexity of the condition and the specialized nature of the test, this investment can be crucial for families seeking answers to unexplained symptoms related to glycosylation disorders.